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Abstract: An improved simple and facile synthesis of chromene derivatives by employing three-
component one-pot condensation reaction of β-naphthol, aromatic aldehydes, and malononitrile in ionic 
liquids is described. The ionic liquid can be reused and recycled. The chromene derivatives were 
evaluated for their anti-proliferative activity for human breast adenocarcinoma (MCF-7), ovarian 
adenocarcinoma (SK-OV-3), and acute lymphoblastic leukemia (CCRF-CEM) cell lines. Compounds 4b 
inhibited the cell proliferation of all three cancer cells by 60-80% at 50 µM. Among all compounds, 
compound 4b was the most potent against all three cancer cell lines whereas compound 4c, 4o and 4p 
exhibited more selectivity against CCRF-CEM. 
 
Introduction  
 
Chromenes and its fused derivatives are 
considered to be important biologically 
active heterocyclic compounds. They are 
main component of many naturally 
occurring products such as, alkaloids, 
flavonoids, tocopherols, and anthocyanins.[1] 
Among different types of chromene systems, 
2-amino-4H-chromenes are of particular 
interest as they belong to privileged 
medicinal scaffold serving for generation of 
small-molecule ligands with highly 
---------------------------------------------------------------- 
Corresponding Author*: E-mail: anilkumar@bits-
pilani.ac.in; Fax: +91-1596-244183; Tel: +91-1596-
245073-279; 
pronounced spasmolitic, diuretic, anti-
coagulant, or anti-anaphylactic activities.[1] 
They have also been shown to exhibit other 
biological activities such as anti-
bacterial,[2,3] anti-viral,[4,5] anti-fungal,[6,7] 
anti-tumor,[8]  hypotensive effects,[9] and 
central nervous system (CNS) activity.[10]  
 
4H-Chromene-3-carboxylate derivatives 
have been known as antagonist of the anti-
apoptotic proteins. A series of analogues 
with varied functional groups at the 6-
position of the chromene ring has been 
evaluated for their binding interactions with 
three anti-apoptotic proteins: Bcl-2, Bcl-XL, 
and Bcl-w.[11] The 4-aryl-4H-chromenes 
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inhibit tubulin polymerization and bind at or 
close to the binding site of colchicine. They 
are also active in the multidrug resistant 
MES-SA/DX5 tumor cells, and are highly 
active as single agent in combination with 
other anti-cancer agents in several tumor 
animal models. Several potent 7-substituted 
and 7,8-disubstituted analogues (Figure 1, 
A-D) have been identified as lead 
compounds for anti-tumor activities through 
SAR studies. 
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Figure 1: Structures of anti-tumor chromenes. 
The most common method for the synthesis 
of chromenes is condensation of phenol, 
aldehyde, and malononitrile in the presence 
of an organic base, such as piperdine.[12] 
Several other reagents, such as CTACl,[13] 
Mg/Al hydrotalcite,[14] K2CO3 in water under 
microwave irradiation,[15] InCl3,[16] KF or 
NaOAc[1], preyssler type heteropolyacid,[17] 
DBU[18], aqueous medium,[19] basic ionic 
liquid[20] and γ-alumina[21] have been 
reported to be effective catalysts for the one-
pot synthesis of 2-aminochromenes. Most of 
these methods require longer reaction time, 
harsh reaction conditions, give low yields, 
and/or uses organic solvents. Recently, 4-
unsubstituted 2-amino-4H-chromene-2-
carbonitriles were synthesized in water using 
DBU as catalyst.[22] An organocatalytic 
asymmetric synthesis of chiral 2-amino-4H-
chromene derivatives was reported by 
tandem Michael addition–cyclization of 
malononitrile to nitroalkenes.[23] 
Ionic liquids are organic salts, which consist 
entirely of ions, and are liquid at or below 
100 °C. They have been shown to have 
several advantages, such as low vapor 
pressure, high thermal stability and 
recyclability over volatile organic 
compounds.7,8 Due to their unique chemical 
properties they have been extensively used 
as solvent, reagent and catalyst in organic 
synthesis. 1-Butyl-3-methylimidazolium-
based ionic liquids are the most commonly 
used in organic synthesis among different 
ionic liquids. These ionic liquids are not 
only used as solvent but they also affect the 
rate of the reaction and thus act as catalyst in 
several organic reactions. The reactivity and 
selectivity for various organic reactions is 
different in ionic liquids compared to 
molecular organic solvents.[24-26] The rate of 
reaction and product selectivity are  
influenced by the nature of ionic liquid 
used.[27] Herein, we report an improved 
simple and facile synthesis of 2-
aminochromene derivatives (4) by 
employing three-component one-pot 
condensation reaction of β-naphthol (1), 
aromatic aldehydes (2), and malononitrile 
(3) in 3-butyl-1-methylimidazolium 
hexafluorophosphate, [bmim][PF6] ionic 
liquid (Scheme 1). 
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Scheme 1: Ionic liquid mediated synthesis of 2-
aminochromenes. 
Materials and methods: 
 
Melting points were measured on a Micro 
scientific works apparatus and are 
uncorrected. IR spectra were recorded on 
Shimadzu FT-IR spectrometer. The 1H 
NMR spectra were recorded on a Bruker 
Heaven 11400 (400 MHz) spectrometer 
using TMS as internal standard and DMSO-
d6 as solvent and the chemical shifts are 
expressed in ppm. Reactions were monitored 
by using thin layer chromatography (TLC) 
on 0.2 mm silica gel F254 plates (Merck). 
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Malononitrile and naphthols were purchased 
from SD Fine and aldehydes were purchased 
from Sigma-Aldrich.  
 
General procedure for preparation of 2-
aminochromenes: 2-Naphthol (1 eq), 4-
chlorobenzaldehyde (1 eq), and 
malononitrile (1 eq) were taken in 10 mL 
round bottom flask containing 1.5 mL 
[bmim][PF6] ionic liquid. The reaction 
mixture was heated to 80 °C for 2 h. The 
reaction was monitored by TLC. After 
completion of the reaction, ethanol was 
added to the crude product; the solid was 
collected by filtration and dried under 
vacuum. The compound was purified by 
recrystalization in ethanol. All the 
compounds were characterized by 1H NMR, 
IR spectroscopy, and mass spectrometry. 
3-Amino-1-(4-chlorophenyl)-1H-
benzo[f]chromene-2-carbonitrile (4a): IR 
(KBr) 3415-3331, 2198, 1643, 1591, 1400, 
1259, 1102, 1045, 808, 760 cm-1; 1H NMR 
(400 MHz, DMSO-d6) δ 7.81 (t, J = 7.86 
Hz, 2H, ArH), 7.59 (dd, J = 9.56 & 6.72 Hz, 
1H, ArH), 7.39 (dd, J = 5.8 & 6.8 Hz, 2H, 
ArH), 7.25 (d, J =1.32 Hz , 1H, ArH), 7.22 
(d, J = 8.94 Hz, 2H, ArH), 7.10 (d, J = 8.4 
Hz, 2H, ArH), 5.2 (s, 1H, CH), 4.63 (bs, 2H, 
NH2); 13C NMR (126 MHz, DMSO-d6) δ 
160.16, 147.25, 145.11, 131.62, 131.27, 
130.49, 130.14, 129.21, 128.95, 127.61, 
125.44, 123.98, 120.78, 117.24, 115.60, 
57.88, 37.81; HRMS (ESI): m/z calcd. for 
C20H14ClN2O+ 333.0789; found 333.0391 
[M + H]+. 
3-Amino-1-(4-nitrophenyl)-1H-
benzo[f]chromene-2-carbonitrile (4b): IR 
(KBr) 3460-3325, 2185, 1665, 1600, 1570, 
1540, 1500, 1325, 1270, 1190, 1080, 760 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 8.10 
(dd, J = 6.96 & 6.92 Hz, 2H, ArH), 7.82-
7.86 (m, 2H, ArH), 7.54-7.58 (m, 1H, ArH), 
7.35-7.42 (m, 4H, ArH), 7.30 (d, J = 9.0 Hz, 
1H, ArH), 6.05 (bs, 2H, NH2), 5.35 (s, 1H, 
CH); 13C NMR (101 MHz, DMSO-d6) δ 
163.77, 155.64, 151.13, 135.29, 134.18, 
132.61, 131.90, 131.39, 129.19, 128.17, 
127.01, 120.62, 117.45, 42.58; HRMS 
(ESI): m/z calcd. for C20H14N3O3+ 344.1030; 
found 344.0623 [M + H]+.  
3-Amino-1-(3-nitrophenyl)-1H-
benzo[f]chromene-2-carbonitrile (4c): IR 
(KBr) 3470-3350, 2185, 1660, 1600, 1580, 
1540, 1500, 1335, 1270, 1080, 760 cm-1; 1H 
NMR (400 MHz, DMSO-d6) δ 8.02 (d, J = 
8.16 Hz, 1H, ArH), 7.97 (s, 1H, ArH), 7.82 
– 7.87 (m, 2H, ArH), 7.61 (d, J = 8.28 Hz, 
2H, ArH), 7.39-7.51 (m, 3H, ArH), 7.31 (d, 
J = 9.0 Hz, 1H, ArH), 6.00 (bs, 2H, NH2), 
5.36 (s, 1H, CH); 13C NMR (101 MHz, 
DMSO-d6) δ 165.17, 153.12, 152.17, 
138.89, 136.05, 135.62, 135.18, 133.78, 
132.58, 130.33, 128.66, 127.01, 126.51, 
125.36, 122.05, 119.77, 62.20, 42.54. 
HRMS (ESI): m/z calcd. for C20H14N3O3+: 
344.1030; found: 344.0625 [M + H]+. 
3-Amino-1-p-tolyl-1H-benzo[f]chromene-2-
carbonitrile (4d): IR (KBr) 3460-3350, 
2975, 2170, 1665, 1600, 1540, 1500, 1270, 
1190, 1080, 760 cm-1; 1H NMR (400 MHz, 
DMSO-d6) δ 7.79 (d, J = 8.4 Hz, 2H, ArH), 
7.70 (t, J = 6.87 Hz, 1H, ArH), 7.37 (dd, J = 
5.2 & 4.6 Hz, 2H, ArH), 7.26 (d, J = 8.92 
Hz, 1H, ArH), 7.02 – 7.07 (m, 4H, ArH), 
5.62 (bs, 2H, NH2), 5.16 (s, 1H, CH), 2.20 
(s, 3H, Ar-CH3); 13C NMR (101 MHz, 
DMSO-d6) δ 160.03, 147.20, 143.25, 
136.11, 131.25, 130.63, 129.83, 129.67, 
128.87, 127.39, 125.31, 124.09, 120.98, 
117.21, 116.23, 58.51, 38.20, 20.99; HRMS 
(ESI): m/z calcd. for C21H17N2O+ 313.1335; 
found: 313.0973 [M + H]+. 
3-Amino-1-(4-methoxyphenyl)-1H-
benzo[f]chromene-2-carbonitrile (4e): IR 
(KBr) 3460-3350, 2985, 2180, 1665, 1600, 
1540, 1500, 1300, 1250, 1190, 1080, 760 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 7.78 
(d, J = 8.88 Hz, 2H, ArH), 7.70 (t, J = 7.3 
Hz, 1H, ArH), 7.35 – 7.40 (m, 2H, ArH), 
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7.25 (d, J = 8.92 Hz , 1H, ArH), 7.09 (d, J = 
8.5 Hz, 2H, ArH), 6.76 (d, J = 8.48 Hz, 2H, 
ArH), 5.63 (bs, 2H, NH2), 5.16 (s, 1H, CH), 
3.70 (s, 3H, Ar-OCH3); 13C NMR (101 
MHz, DMSO-d6) δ 164.74, 163.02, 151.88, 
143.10, 136.01, 135.37, 134.54, 133.62, 
133.23, 132.19, 130.05, 128.88, 125.76, 
121.97, 121.15, 119.23, 63.41, 60.16, 42.49; 
HRMS (ESI): m/z calcd. for C21H17N2O2+ 
329.1285; found: 329.0898 [M + H]+. 
3-Amino-1-(3-chlorophenyl)-1H-
benzo[f]chromene-2-carbonitrile (4f): IR 
(KBr) 3400-3270, 2180, 1670, 1400, 1102, 
1045, 808, 760 cm-1; 1H NMR (400 MHz, 
DMSO-d6) δ 7.82 (d, J = 7.9 Hz, 2H, ArH), 
7.65 (d, J = 6.7, 1H, ArH), 7.41(dd, J = 5.3 
& 3.3 Hz, 2H, ArH), 7.28 (d, J = 9.0 Hz, 1H, 
ArH), 7.21 (t, J = 7.4 Hz, 1H, ArH), 7.13 (d, 
J = 8.2 Hz, 2H, ArH), 7.09 (s, 1H, ArH), 
5.88 (bs, 2H, NH2), 5.19 (s, 1H, CH); 13C 
NMR (101 MHz, DMSO-d6) δ 160.28, 
148.59, 147.32, 133.65, 131.21, 130.47, 
130.24, 128.98, 127.71, 127.13, 126.16, 
125.51, 123.96, 120.71, 117.26, 115.40, 
57.75, 37.97; HRMS (ESI): m/z calcd. for 
C20H14ClN2O+ 333.0789; found: 333. 0389 
[M + H]+. 
3-Amino-1-(3-methoxyphenyl)-1H-
benzo[f]chromene-2-carbonitrile (4g): IR 
(KBr) 3460-3350, 2985, 2180, 1665, 1600, 
1540, 1500, 1300, 1250, 1190, 1080, 760 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 7.81 
(d, J = 9.1 Hz, 2H, ArH), 7.69 – 7.73 (m, 
2H, ArH), 7.36 – 7. 42 (m, 1H, ArH), 7.27 
(d, J = 8.9 Hz, 1H, ArH), 7.14 – 7.18 (m, 
1H, ArH), 6.77 (d, J = 7.7 Hz, 1H, ArH), 
6.67 – 6.69 (m, 2H, ArH), 6.05 (bs, 2H, 
NH2), 5.16 (s, 1H, CH), 3.73 (s, 3H, Ar-
OCH3); 13C NMR (101 MHz, DMSO-d6) δ 
160.20, 159.78, 147.68, 147.26, 131.23, 
130.66, 130.29, 129.93, 128.88, 127.53, 
125.38, 124.08, 120.93, 119.61, 117.18, 
116.03, 113.87, 111.62, 58.22, 55.36, 38.41; 
HRMS (ESI): m/z calcd. for C21H17N2O2+ 
329.1285; found: 329.0898 [M + H]+. 
3-Amino-1-phenyl-1H-benzo[f]chromene-
2-carbonitrile (4h): IR (KBr) 3460-3350, 
2180, 1665, 1600, 1540, 1500, 1190, 1080 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 7.83 
(dd, J = 9 & 9.3 Hz, 2H, ArH), 7.75 (d, J = 
6.8 Hz, 1H, ArH), 7.35 – 7.41 (m, 2H, ArH), 
7.12 – 7.30 (m, 6H, ArH), 6.60 (bs, 2H, 
NH2), 5.20 (s, 1H, CH); 13C NMR (101 
MHz, DMSO-d6) δ 160.14, 147.27, 146.15, 
131.26, 130.61, 129.93, 129.13, 128.90, 
127.47, 127.03, 125.35, 124.06, 120.95, 
117.22, 116.12, 58.37, 38.54; HRMS (ESI): 
m/z calcd. for C20H15N2O+ 299.1179; found: 
299.048 [M + H]+. 
3-Amino-1-(4-chlorophenyl)-9-methoxy-
1H-benzo[f]chromene-2-carbonitrile (4i): 
IR (KBr) 3460-3350, 2985, 2180, 1665, 
1600, 1540, 1500, 1300, 1250, 1190, 1080, 
808, 760 cm-1; 1H NMR (400 MHz, DMSO-
d6) δ 7.73 – 7.60 (m, 2H, ArH), 7.22 (dd, J = 
6.5 & 6.59 Hz, 2H, ArH), 7.15 (dd, J = 6.6 
& 6.4 Hz, 2H, ArH), 7.10 (d, J = 8.8 Hz, 1H, 
ArH), 7.02 (dd, J = 8.88 & 8.92 Hz, 1H, 
ArH), 6.86 (d, J = 2.3 Hz, 1H, ArH), 5.86 
(bs, 2H, NH2), 5.10 (s, 1H, CH), 3.71 (s, 3H, 
Ar(naphthyl)-OCH3); 13C NMR (101 MHz, 
DMSO-d6) δ 160.13, 158.49, 147.70, 
145.18, 132.02, 131.56, 130.49, 129.70, 
129.48, 129.07, 126.43, 120.83, 117.33, 
114.88, 114.49, 103.56, 57.87, 55.61, 37.76; 
HRMS (ESI): m/z calcd. for C21H16ClN2O2+ 
363.0895; found: 363.0478 [M + H]+. 
3-Amino-9-methoxy-1-(3-nitrophenyl)-1H-
benzo[f]chromene-2-carbonitrile (4j): IR 
(KBr) 3470-3350, 2960, 2185, 1660, 1600, 
1580, 1540, 1500, 1335, 1270, 1080, 760 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 8.02 
– 8.04 (m, 2H, ArH), 7.64 – 7.77 (m, 3H, 
ArH), 7.48 – 7.52 (m, 1H, ArH), 7.15 (d, J = 
8.9 Hz, 1H, ArH), 7.02 (dd, J = 8.88 & 8.92 
Hz, 1H, ArH), 6.89 (d, J = 2.2 Hz, 1H, 
ArH), 6.22 (bs, 2H, NH2), 5.31 (s, 1H, CH), 
3.72 (s, 3H, Ar(Naphthyl)-OCH3); 13C NMR 
(101 MHz, DMSO-d6) δ 160.46, 158.68, 
148.36, 147.80, 134.37, 131.89, 130.84, 
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130.59, 130.03, 126.45, 122.27, 121.97, 
120.69, 117.59, 114.50, 103.35, 57.36, 
55.64, 37.66; HRMS (ESI): m/z calcd. for 
C21H16N3O4+ 374.1135; found: 374.0721 [M 
+ H]+. 
3-Amino-1-(3-chlorophenyl)-9-methoxy-
1H-benzo[f]chromene-2-carbonitrile (4k): 
IR (KBr) 3460-3350, 2985, 2180, 1665, 
1600, 1540, 1500, 1300, 1250, 1190, 1080, 
808, 760 cm-1; 1H NMR (400 MHz, DMSO-
d6) δ 7.73 – 7.68 (m, 2H, ArH), 7.11 – 7.26 
(m, 5H, ArH), 7.01 (dd, J = 8.88 & 8.84 Hz, 
1H), 6.94 (d, J =2.3 Hz, 1H, ArH), 5.14 (s, 
1H, CH), 6.40 (bs, 2H, NH2), 3.73 (s, 3H, 
Ar(naphthyl)-OCH3); 13C NMR (101 MHz, 
DMSO-d6) δ 160.25, 158.53, 148.66, 
147.71, 133.57, 132.00, 131.08, 130.52, 
129.79, 127.44, 127.08, 126.42, 120.81, 
117.40, 114.68, 114.51, 103.54, 57.71, 
55.58, 38.00; HRMS (ESI): m/z calcd. for 
C21H16ClN2O2+ 363.0895; found: 363.0477 
[M + H]+. 
3-Amino-9-methoxy-1-(3-methoxyphenyl)-
1H-benzo[f]chromene-2-carbonitrile (4l): 
IR (KBr) 3460-3350, 2985, 2180, 1665, 
1600, 1540, 1500, 1300, 1250, 1190, 1080, 
760 cm-1; 1H NMR (400 MHz, DMSO-d6) δ 
7.69 (t, J = 7.89 Hz, 2H, ArH), 7.20 – 7.17 
(m, 1H, ArH), 7.10 (d, J = 8.8 Hz, 1H, 
ArH), 7.00 (dd, J = 8.88 & 8.84 Hz, 1H, 
ArH), 6.96 (d, J = 2.2 Hz, 1H, ArH), 6.84 
(d, J = 7.7 Hz, 1H, ArH), 6.70 (dd, J = 9.0 & 
7.9 Hz, 2H, ArH), 5.06 (s, 1H, CH), 5.82 
(bs, 2H, NH2), 3.71 (s, 6H, Ar-OCH3); 13C 
NMR (101 MHz, DMSO-d6) δ 160.15, 
159.76, 158.39, 147.73, 132.18, 130.41, 
130.20, 129.49, 126.40, 120.97, 119.91, 
117.28, 115.32, 114.46, 113.95, 111.77, 
103.68, 58.21, 55.47, 38.43; HRMS (ESI): 
m/z calcd. for C22H19N2O3+ 359.1390; found: 
359.0991 [M + H]+. 
3-Amino-9-methoxy-1-(4-nitrophenyl)-1H-
benzo[f]chromene-2-carbonitrile (4m): IR 
(KBr) 3470-3350, 2960, 2185, 1660, 1600, 
1580, 1540, 1500, 1335, 1270, 1080, 760 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 8.10 
(dd, J = 8.7 & 9.2 Hz, 2H, ArH), 7.76 (d, J = 
8.9 Hz, 1H, ArH ), 7.71 (d, J = 8.9 Hz, 1H, 
ArH ), 7.44 (d, J = 8.7 Hz, 2H, ArH), 7.13 
(d, J = 8.8 Hz, 1H, ArH), 7.00 (dd, J = 8.88 
& 8.92 Hz, 1H, ArH), 6.88 (d, J = 2.2 Hz, 
1H, ArH), 5.33 (s, 1H, CH), 6.62 (bs, 2H, 
NH2), 3.71 (s, 3H, Ar(naphthyl)-OCH3); 13C 
NMR (101 MHz, DMSO-d6) δ 160.36, 
158.65, 153.53, 147.81, 146.62, 131.97, 
130.57, 130.03, 128.84, 126.44, 124.51, 
120.63, 117.46, 114.54, 114.19, 103.41, 
57.05, 55.65, 38.04; HRMS (ESI): m/z 
calcd. for C21H16N3O4+ 374.1135; found: 
374.0692 [M + H]+.  
3-Amino-1-(pyridin-4-yl)-1H-
benzo[f]chromene-2-carbonitrile (4n): IR 
(KBr) 3470-3350, 2960, 2185, 1660, 1600, 
1540, 1500, 1270, 1080 cm-1; 1H NMR (400 
MHz, DMSO-d6) δ 8.4 (s, 2H, ArH), 7.84 (t, 
J = 7.9 Hz, 2H, ArH), 7.58 (t, J = 7.4 Hz, 
1H, ArH), 7.41 (dd, J = 6.16 & 6.24 Hz, 2H, 
ArH), 7.29 (d, J = 9.0 Hz, 1H, ArH), 7.15 – 
7.13 (m, 2H, ArH), 6.09 (bs, 2H, NH2), 5.22 
(s, 1H, CH); 13C NMR (101 MHz, DMSO-
d6) δ 160.47, 154.17, 150.52, 147.44, 
131.25, 130.42, 129.01, 127.76, 125.55, 
123.82, 122.63, 120.58, 117.25, 114.64, 
56.79, 37.72; HRMS (ESI): m/z calcd. for 
C19H14N3O+ 300.1131; found: 300.0666 [M 
+ H]+.  
2-Amino-4-(4-chlorophenyl)-4H-
benzo[h]chromene-3-carbonitrile (4o): IR 
(KBr) 3470-3350, 2185, 1660, 1600, 1540, 
1500, 1270, 1080, 800, 760 cm-1; 1H NMR 
(400 MHz, DMSO-d6) δ 4.85 (s, 1H, CH), 
6.00 (bs, 2H, NH2), 6.99 (d, J = 8.44 Hz, 
1H, ArH) 7.19 (d, J = 8.44 Hz, 2H, ArH), 
7.27 (d, J = 8.4, 2H, ArH), 7.49 – 7.58 (m, 
3H, ArH), 7.83 (d, J = 7.28 Hz 1H, ArH), 
8.25 (d, J = 7.92 Hz, 1H, ArH); 13C NMR 
(101 MHz, DMSO-d6) δ 157.15, 150.28, 
141.32, 135.34, 131.21, 129.12, 129.14, 
128.34, 127.23, 127.03, 126.45, 125.38, 
125.18, 124.24, 122.14, 111.14, 57.19, 
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41.18.; HRMS (ESI): m/z calcd. for 
C20H14ClN2O+ 333.0789; found: 333. 0389 
[M + H]+. 
2-Amino-4-(3-methoxyphenyl)-4H-
benzo[h]chromene-3-carbonitrile (4p): IR 
(KBr) 3460-3350, 2985, 2180, 1665, 1600, 
1540, 1500, 1300, 1250, 1190, 1080, 760 
cm-1; 1H NMR (400 MHz, DMSO-d6) δ 3.70 
(s, 1H, OCH3), 4.75 (s, 1H, CH), 6.01 (bs, 
2H, NH2), 6.90 (d, J = 8.44 Hz, 1H, ArH) 
7.15 (d, J = 8.44 Hz, 2H, ArH), 7.20 (d, J = 
8.4, 2H, ArH), 7.41 – 7.58 (m, 3H, ArH), 
7.75 (d, J = 7.28 Hz 1H, ArH), 8.19 (d, J = 
7.92 Hz, 1H, ArH); 13C NMR (101 MHz, 
DMSO-d6) δ 159.92, 157.15, 150.39, 
143.21, 134.56, 130.12, 129.13, 127.25, 
126.65, 126.24, 126.13, 125.26, 124.22, 
124.04, 122.12, 116.34, 115.14, 111.28, 
59.28, 57.25, 40.6; HRMS (ESI): m/z calcd. 
for C21H17N2O2+ 329.1285; found: 329.0898 
[M + H]+. 
 
Results and Discussion 
 
Initially, we reacted β-naphthol, 4-
chlorobenzaldehyde, and malononitrile in 
[bmim][PF6] ionic liquid at 80 °C for 2 h. 
The reaction gave an excellent yield (86 %) 
for 4a. We also tried different ionic liquids, 
such as [bmim][Br], [bmim][BF4], n-
butylpyridinium bromide, cetylpyridinium 
chloride, and n-butylpyridinium 
dodecylsulfate for the synthesis of 4a. 
Among all these ionic liquids, [bmim][PF6] 
gave the highest yield of 4a. The yields of 
4a under different conditions are given in 
Table 1. The higher reactivity of 
[bmim][PF6], may be due to the fact that it 
has higher Bronsted acidity and it is 
hydrophobic in nature, whereas other ionic 
liquids used are miscible with water. The 
immiscibility of [bmim][PF6] ionic liquid 
and water may result in biphasic 
environment in the reaction. We also studied 
the model reaction with different catalyst 
such as 1,8-diazabicyclo[5.4.0]undec-7-en 
(DBU), L-proline, benzyltrimethyl-
ammonium chloride and tetrabutyl-
ammonium fluoride (TBAF) in aqueous 
medium. The yield of 4a was moderate 
(Table 1) and required longer reaction time. 
 
The structure of 4a was confirmed by 1H, 
13C NMR, and mass analysis. In 1H NMR 
spectrum of 4a a signal appeared as a singlet 
at δ 5.71 for CH proton and NH2 protons 
resonated as a broad peak at δ 4.63. All the 
other protons were in good agreement with 
the proposed structure. In 13C NMR 
spectrum of 4a CH carbon appeared at δ 
37.81 and CH-carbon adjacent to cyano 
group resonated at δ 57.88. All the 
remaining carbons were in agreement with 
required structure. In ESI-MS spectrum of 
4a, a peak appeared at m/z 333.0391 for [M 
+ H]+ ion. 
Table 1 Synthesis of 4a under different reaction conditions. 
Entry Catalyst Time (h) Yield (%)a 
1 [bmim][BF4] 2 71 
2 [bmim][Br] 2 50 
3 [bmim][PF6] 2 86 
4 n-Butylpyridinium bromide 2 50 
5 n-Butyl pyridinium dodecylsulfate 12 -b 
6 Cetylpyridinium chloride 3 70 
7 DBU 4 60c 
8 Ferric ammonium citrate 12 8c 
9 L-Prolein 3 70c 
10 TBAF 4 50c 
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11 Citric acid 4 -b,c 
12 Amberlyst A26 (OH) 4 -b,c 
13 SDS 4 -b,c 
14 Boric acid 4 -b,c 
15 Yb(OTf)3  4 -b,c 
16 Benzyltrimethylammonium chloride 4 68b 
aYields refer to pure isolated compounds, bNo desired compound, cWater is the reaction media. 
After optimizing the reaction condition, we 
examined generality of the reaction by 
varying aldehydes and naphthols. All the 
substrate gave excellent yield of the 
corresponding substituted 2-amino-
chromenes (4). The yields of different 
substituted 2-aminochromenes (4a-p) are 
given in Table 2. It is worth to mention that 
aldehydes with both electron-donating and 
electron-withdrawing groups reacted 
smoothly and gave corresponding product in 
excellent yields. The method also works 
well with α-naphthol and substituted β-
naphthol. Simple reaction condition, easy 
work-up, and high yield under 
environmental friendly condition are 
advantages of the method. 
The recovery and reuse of [bmim][PF6] was 
also examined, and model reaction was 
performed using starting materials (1a, 2a, 
3). After completion of reaction, ethanol was 
added to the reaction mixture and the 
precipitate was filtered. The filtrate was 
concentrated on rotatory evaporator to 
recover ionic liquid, which was dried under 
vacuum at 60 oC for 30 min. The recovered 
[bmim][PF6] was again used for the 
synthesis of 4a following the standardized 
reaction condition. This was repeated five 
times. The recovered ionic liquid could be 
used efficiently for the synthesis of 4a and 
there was no appreciable decrease in yield of 
4a (Table 3).  
 
Table 2 Synthesis of chromene derivatives (4a-p) in [bmim][PF6] ionic liquid.  
Sr. 
No. R R
′ Product Time (h) 
Yield 
(%)a 
M.p (Lit. 
M.p) °C 
1 H 4-Cl O
CN
NH2
Cl
4a 2 86 210-212 (208)[28] 
2 H 4-NO2 O
CN
NH2
O2N
4b 2 70 168-170 (186)[29] 
3 H 3-NO2 
O
CN
NH2
NO2
4c 2 86 233-235 (239)[30] 
4 H 4-Me O
CN
NH2
H3C
4d 2 76 268-270 (253)[29] 
5 H 4-OMe O
CN
NH2
MeO
4e 2 74 199-201 (194)[29] 
6 H 3-Cl 
O
CN
NH2
Cl
4f 2 82 236-238 (240)[29] 
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7 H 3-OMe 
O
CN
NH2
OMe
4g 2 81 256-258 (263)[29] 
8 H H O
CN
NH2
 
4h 2 86 286-288 (279)[29] 
9 7-OMe 4-Cl O
CN
NH2
Cl
MeO 4i 2 79 257-259 
10 7-OMe 3-NO2 O
CN
NH2
MeO
NO2
4j 2 90 248-250 
11 7-OMe 3-Cl 
O
CN
NH2
MeO
Cl
4k 2 81 260-262 
12 7-OMe 3-OMe 
O
CN
NH2
MeO
OMe
4l 2 82 205-207 
13 7-OMe 4-NO2 O
CN
NH2
O2N
MeO 4m 2 86 239-241 
14 H 4-pyridyl O
CN
NH2
N
4n 2 89 229-231 
15 1-OH 4-Cl O
CN
NH2
Cl
4o 2 81 235-237 (232)[31] 
16 1-OH 3-OMe O
CN
NH2
OCH3 4p 2 78 231-233 
aYields refer to pure and isolated products. 
 
Table 3: Recycling of ionic liquid for 
synthesis of 4a 
Run 1 2 3 4 5 
Yield (%)a 86 83 82 80 76 
aIsolated yield. 
The role of ionic liquid in the reaction is not 
clear, but it is believed that it activates the 
aldehydes and malonitrile by coordinating 
through C-2 proton of imidazolium ion. 
Such activation of reactions due to acidic C-
2 proton of imidazolium ionic liquids have 
been previously reported in literature.[32] It is 
proposed that the reaction either proceeds 
through o-quinone methide intermediate (B) 
mechanism (path a) or via Knoevenagel 
condensation followed by Friedel-Craft 
alkylation and cyclization (path b) (Scheme 
2). In path a, o-QM is formed by the reaction 
of aldehyde and β-naphthol, which then 
reacts with active methylene group of 
malononitrile to form dicyano compound 
(C). In path b, first malonitrile reacts with 
aldehyde to give α,β-unsaturated nitrile (E) 
which then reacts with naphthol to give 
dicyano compound (C). The dicyano 
compound cyclizes to 2-aminochromenes 
(4). 
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O
HOOHO H
-H2O
OH
O
H
B (o-QM)
H
[bmim][PF6]
CN
N O
CN
NH
H
A
C D
N
N
Me
Bu
H δ
δ
CH2(CN)2
O
CN
NH2
Path a
O H
N
N
Me
Bu
H δ
δ
CH2(CN)2
OH
CN
NC
4
E
Path b
 
Scheme 2 Proposed mechanism for the formation of 4.  
Mutations and/or overexpression of Src 
kinase (Src), a prototype member of the Src 
family of kinases (SFKs) have been 
implicated in the development of several 
types of human tumors including breast, 
ovary, colon, pancreas, prostate, and lung.[33] 
Increased Src activity is observed in 
metastatic tumors and it also regulates 
specific angiogenic factors that promote 
tumor progression.[34] Thus, designing 
potent and selective Src kinase inhibitors as 
anti-cancer agents is a subject of major 
interest.[35,36] 4-Aryl substituted derivatives 
of 2-amino-7-dimethylamino-4H-chromene-
3-carbonitrile have been evaluated for 
inhibition of Src kinase and anticancer 
activity.[37-39] Therefore, the synthesized 
chromene derivatives 4a-p were studied for 
c-Src kinase inhibition (Table 4). Among the 
all the compounds, 4b, 4c, 4j, 4k, and 4i 
showed modest inhibition of c-Src kinase 
with IC50 values below 100 μM, whereas 
other compounds were either poor Src 
kinase inhibitory activity or did not show 
any inhibition. Among all the compounds, 4-
nitro derivative exhibited the highest Src 
kinase inhibitory activity with an IC50 value 
of 40 µM.  
 
Table 4 Src-kinase inhibitory activity of 4a-
p. 
Sr. 
No. Compd.
IC50 
(µM)a 
Sr. 
No. Compd.
IC50 
(µM)a
1 4a 150 10 4i >200 
2 4b 40 11 4j 80 
3 4c 80 12 4k 50 
4 4d 100 13 4l 65 
5 4e 150 14 4m 100 
6 4f 150 15 4n 150 
7 4g 150 16 4o >200 
8 4h >200 17 4p 150 
9 PPI 0.6    
aThe concentration of the compound that inhibited 
enzyme activity by 50%. 
The effect of compounds 4a-p (50 µM) on 
the proliferation of selected cancer cell lines 
such as human breast adenocarcinoma 
(MCF-7), ovarian adenocarcinoma (SK-OV-
3) and acute lymphoblastic leukemia 
(CCRF-CEM) was evaluated (Figure 2). 
Compound 4b inhibited the cell proliferation 
of all three cancer cells by 60-80% at 50 
µM. Compound 4b was the most potent 
compound against all three cell lines 
whereas 4c, 4o and 4p showed higher 
selectivity against CCRF-CEM among all 
the screened compounds. Interestingly, 
compound 4b was also the most potent Src 
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kinase inhibitor in this class, suggesting that 
Src kinase inhibition could have contributed 
to anti-proliferative activity of this 
compound. 
0
50
100
150
200
250
SK‐OV‐3
MCF‐7
CCRF‐CEM
 
Figure 2. Anti-proliferative activity of chromene derivatives 4a-p. 
Conclusion 
 
In conclusion, we have described an 
efficient, simple and eco-friendly method for 
the synthesis of 2-aminochromene 
derivatives by employing three-component 
one-pot condensation reaction using 
[bmim][PF6] ionic liquid as solvent and 
catalyst. This method has advantage of 
simple reaction work up, easy isolation of 
product, recycle and reuse of catalyst, and 
high yields of product. All the synthesized 
chromene derivatives were evaluated for 
inhibition of Src kinase activity and anti-
proliferative activities. Compound 4b was 
most potent compound for all three cell lines 
whereas compound 4c, 4o and 4p was most 
selective for (CCRF-CEM). Compounds 4b 
and 4k showed modest inhibition of c-Src 
kinase with IC50 values below 50 μM. These 
data provide an efficient strategy for the 
synthesis of 2-aminochromene derivatives. 
Potential compounds can be optimized and 
investigated further as lead anti-proliferative 
agents.  
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